---
figid: PMC7133220__nihms-1552319-f0009
figtitle: Putative mechanisms by which neratinib down-regulates mutant K-RAS expression
  and inactivates Hippo Pathway function
organisms:
- NA
pmcid: PMC7133220
filename: nihms-1552319-f0009.jpg
figlink: pmc/articles/PMC7133220/figure/F9/
number: F9
caption: Neratinib via inhibition of MST3/4 causes Rubicon-dependent phagocytosis
  and in parallel, neratinib activates ATM-AMPK signaling that causes autophagosome
  formation. Collectively, this results in the cathepsin-dependent degradation of
  mutant K-RAS. Atorvastatin via reduced prenylation and sildenafil via increased
  PKG-dependent phosphorylation of K-RAS also independently act to lower mutant K-RAS
  levels. As part of this process at the plasma membrane, neratinib reduces PAK1 phosphorylation
  that leads to dephosphorylation of the PAK1 substrate Merlin/NF2. Dephosphorylated
  Merlin facilitates activation of LATS1/2, and active LATS1/2 phosphorylate YAP and
  TAZ. Phosphorylated YAP and TAZ leave the nucleus, preventing them from acting as
  transcriptional coactivators.
papertitle: Neratinib inhibits Hippo/YAP signaling, reduces mutant K-RAS expression,
  ONCOGENE and kills pancreatic and blood cancer cells.
reftext: Paul Dent, et al. Oncogene. ;38(30):5890-5904.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.964123
figid_alias: PMC7133220__F9
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC7133220__F9
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7133220__nihms-1552319-f0009.html
  '@type': Dataset
  description: Neratinib via inhibition of MST3/4 causes Rubicon-dependent phagocytosis
    and in parallel, neratinib activates ATM-AMPK signaling that causes autophagosome
    formation. Collectively, this results in the cathepsin-dependent degradation of
    mutant K-RAS. Atorvastatin via reduced prenylation and sildenafil via increased
    PKG-dependent phosphorylation of K-RAS also independently act to lower mutant
    K-RAS levels. As part of this process at the plasma membrane, neratinib reduces
    PAK1 phosphorylation that leads to dephosphorylation of the PAK1 substrate Merlin/NF2.
    Dephosphorylated Merlin facilitates activation of LATS1/2, and active LATS1/2
    phosphorylate YAP and TAZ. Phosphorylated YAP and TAZ leave the nucleus, preventing
    them from acting as transcriptional coactivators.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Acp95EF
  - Pak
  - mbt
  - Rubicon
  - Kg
  - Pkg21D
  - Gycalpha99B
  - wts
  - Nos
  - nos
  - Taz
  - Dis3
  - yki
  - SNF4Agamma
  - AMPKalpha
  - tefu
  - KRAS
  - STK26
  - STK24
  - ATG16L1
  - PAK1
  - PAK2
  - PAK3
  - PAK4
  - PAK5
  - PAK6
  - RUBCN
  - SGCB
  - GUCY1A2
  - GUCY1A1
  - GUCY1B1
  - GUCY1B2
  - LATS2
  - LATS1
  - NOS1
  - NOS2
  - NOS3
  - PDE5A
  - TAFAZZIN
  - WWTR1
  - YAP1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - CTSA
  - CTSB
  - CTSC
  - CTSD
  - CTSE
  - CTSF
  - CTSG
  - CTSH
  - CTSK
  - CTSL
  - CTSO
  - CTSS
  - CTSV
  - CTSW
  - CTSZ
  - ATM
  - atorvastatin
  - neratinib
  - sildenafil
  - Neratinib
---
